Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H,Jacobsen SD, Moses AC, Molck AM, Nielsen HS, Nowak J, SolbergH, Thi TD, Zdravkovic M 2010 Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin releaseand C-cell proliferation. Endocrinology 151:1473–1486 30.Fineman MS, Shen LZ, Taylor K, Kim DD, Baron AD 2004 Effec- tiveness of progressive dose-escalation of exenatide (exendin-4) inreducing dose-limiting side effects in subjects with type 2 diabetes.Diabetes Metab Res Rev 20:411–417 31.DeFronzo RA, Okerson T, Viswanathan P, Guan X, Holcombe JH, MacConell L 2008 Effects of exenatide versus sitagliptin on post- prandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study. Curr Med ResOpin 24:2943–2952 32.Agersø H, Jensen LB, Elbrond B, Rolan P, Zdravkovic M 2002 The